UPL Ltd.
Chemicals · NSE
52-week range
₹565 – ₹812
From 52w high
-20.5%
RSI (14)
51.3
vs SMA 50 / 200
↑ 50 · ↓ 200
UPL is a large-cap agrochemical company trading at ₹644, currently below its 200-DMA of ₹701.67 and carrying a debt-to-equity ratio of 79.613 alongside a 5-year earnings CAGR of -51.7%. Trailing PE is 30.77 while forward PE sits at 14.93, reflecting consensus expectations of a meaningful earnings recovery. The stock is down 5.54% over the past year and 13.86% over the past 3 months.
- ✓Revenue has grown at a 5-year CAGR of 12.5%, indicating the top line has expanded even as earnings have compressed.
- ✓Free cash flow has been positive in 4 of the available persistence years, demonstrating some capacity to generate cash despite elevated debt.
- ✓Current price of ₹644 is above the 50-DMA of ₹630.99, and RSI sits at 50.29 — a neutral reading that is neither extended nor oversold on this timeframe.
- ✓Mean analyst rating of 1.88 across 17 analysts (1–5 scale, lower = more constructive) reflects a constructive tilt in sell-side coverage.
- ✗5-year earnings CAGR of -51.7% represents a sustained multi-year deterioration in bottom-line profitability, with profit margin currently at 3.58%.
- ✗Debt-to-equity of 79.613 is exceptionally high; with ROE data unavailable and earnings declining, debt serviceability cannot be confirmed from the available data alone.
- ✗Quality score of 30 ranks UPL 4th of 6 sector peers, and the consistency score of 15 with zero years of ROE above 15% reflects weak historical earnings quality.
- ✗Price has remained below the 200-DMA for an extended period, with the stock down 13.86% over the past 3 months and the nearest resistance at ₹671.70 — 4.3% above current price.
- ·UPL scheduled a board meeting on May 11, 2026 to approve FY26 audited financial results and host a Capital Markets Day — an event the market may use to reassess the earnings recovery thesis embedded in the forward PE of 14.93.
- ·UPL's Brazilian arm announced an $86.7 million investment in associate Sinova Inovacoes Agricolas, raising its stake to 55.81%; this incremental capital deployment adds to the group's existing high debt load.
- ·News flow over the past 2 weeks has been uniformly neutral-to-positive (5 positive, 3 neutral, 0 negative across 8 articles), centred on the Sinova investment and the upcoming results event.
- ?Does the 5-year revenue CAGR of 12.5% reflect genuine market share gains in agrochemicals, or is it primarily a function of pricing and currency movements in international markets?
- ?Given a debt-to-equity of 79.613 and a 5-year earnings decline of 51.7%, what specific levers — asset sales, deleveraging, margin recovery — would need to materialise for the forward PE of 14.93 to prove accurate?
- ?The Brazilian Sinova investment adds $86.7 million of capital to a business already carrying heavy debt; how does management frame the return profile and payback horizon for this incremental deployment?
- ?With UPL's quality score (30) roughly matching its lowest-ranked peer Coromandel (30), what distinguishes UPL's competitive positioning or business model within the chemicals sector?
PE
30.8
Forward PE
14.9
ROE
—
Profit margin
+3.6%
D/E
79.61
Dividend yield
+0.9%
Quality score
30/100
ROE 5y above 15%
0/5 yrs
FCF 5y positive
4/5 yrs
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.Analysis generated 11 May 2026.